Economic costs of chemotherapy-induced febrile neutropenia among patients with non-Hodgkin’s lymphoma in European and Australian clinical practice

BACKGROUND: Economic implications of chemotherapy-induced febrile neutropenia (FN) in European and Australian clinical practice are largely unknown. METHODS: Data were obtained from a European (97%) and Australian (3%) observational study of patients with non-Hodgkin’s lymphoma (NHL) receiving CHOP...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Weycker, Derek, Danel, Aurelie, Marciniak, Anne, Bendall, Kate, Lipsitz, Michael, Pettengell, Ruth
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2012
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3488560/
https://ncbi.nlm.nih.gov/pubmed/22913768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-362
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars